Medscape

An Update on Treatment Strategies for Common Variable Immunodeficiency

Common variable immunodeficiency (CVID) is a primary immunological disease with variable severity, ranging from mild forms of infections to chronic progressive complications. The hallmark of this ...
Medscape

Allergy Affects 1 in 4 With Common Variable Immunodeficiency

Over a quarter of patients with common variable immunodeficiency (CVID) had allergy or hypersensitivity reactions and higher immunoglobulin (Ig)E levels than patients without allergies, but overall ...
Nasdaq

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Leiden, the Netherlands, March 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been dosed in a Phase II, proof ...
Medical Xpress

Disease or Syndrome: Common variable immune deficiency

A study just published in the journal Microbiome, describes for the first time the intestinal microbiome and metabolome in patients with (genetically acquired) CTLA4 deficiency. CTLA4 is an immune ...
Monthly Prescribing Reference

FDA Approval Expands Use of Xembify for Primary Immunodeficiency

In treatment-experienced patients, findings showed Xemfiby exposure was similar between weekly and biweekly dosing. The Food and Drug Administration (FDA) has expanded the approval of Xembify ® ...